<DOC>
	<DOCNO>NCT00661895</DOCNO>
	<brief_summary>Clinical trial yet test adequacy HTN control African Americans ( AA ) control intervention group give free antihypertensive medication involve usual versus intensive intervention strategy . Because , yet determine whether method prescribe antihypertensive medication accord JNC 7 guideline , less , equally effective prescribe antihypertensive medication provide intensive behavioral clinical intervention . Knowledge area HTN treatment well able medical health practitioner help AA subject control HTN . The BEAT Hypertension Clinic evaluate method HTN control propose program evaluate difference HTN control among subject receive usual care free medication subject also receive free medication , additionally treat clinic operates intensive manner relationship patient behavior modification , patient-clinician interaction , physical social environment . At conclusion study , BEAT Hypertension Clinic investigator report finding help answer question whether medication alone medication combine intensive behavioral clinical treatment effective HTN control AA population .</brief_summary>
	<brief_title>Black Education Treatment Hypertension ( BEAT HTN )</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Nifedipine</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<mesh_term>Hydralazine</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Atenolol</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<mesh_term>Lisinopril</mesh_term>
	<mesh_term>Clonidine</mesh_term>
	<mesh_term>Doxazosin</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<criteria>1 . Demographics : men woman selfdeclared AfricanAmerican heritage 25 80 year age reside Omaha , Nebraska metropolitan area 2 . History document uncontrolled ( treat untreated ) hypertension ( HTN ) define JNC 7 guideline 3 . Study eligibility base subject 's current blood pressure control base average two seated blood pressure measurement two consecutive clinic visit least one week apart 1 . Untreated subject elevate blood pressure ( &gt; 140/90 mmHg &lt; 130/80 mmHg diabetic ) 2 . Subjects treat antihypertensive therapy whose blood pressure meet current JNC 7 guideline ( &lt; 140/90 mmHg nondiabetics &lt; 130/80 mmHg diabetic ) 1 . Myocardial infarction stroke previous 6 month 2 . Symptomatic heart failure leave ventricular ejection fraction &lt; 35 % 3 . Angina pectoris prior six month 4 . Coronary revascularization procedure prior 6 month 5 . Renal insufficiency define serum creatinine &gt; 2 mg/dl 6 . Illicit drug alcohol abuse prior 6 month 7 . Dementia organic brain disease 8 . Serious systemic illness shorten life expectancy limitation precludes participation trial 9 . Secondary HTN 10 . Concurrent participation investigational medication trial</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>African American</keyword>
</DOC>